Birchtech Q3 product revenue rises 15.7% on mercury emissions products demand

By Reuters News


Overview

  • US activated carbon tech firm's Q3 product revenue rose 15.7% yr/yr, driven by mercury emissions demand

  • Total Q3 revenue fell yr/yr due to no licensing fees versus prior-year quarter

  • Company repurchased shares under $5 mln buyback program in Q3


Outlook

  • Company expects to begin supplying water treatment customers under GAC agreement in early 2027

  • Birchtech aims to convert licensed coal-fired utilities into recurring SEA supply customers in 2027

  • Company plans to advance offtake discussions for its first Carbon Rejuvenation facility in 2027


Result Drivers

  • MERCURY EMISSIONS DEMAND - Co said stronger demand for mercury emissions products, driven by more extreme weather and higher natural gas prices, boosted product revenue

  • WATER TREATMENT SALES - Co said initial sales to the water treatment market contributed to product revenue growth

  • LOWER LEGAL COSTS - Co said SG&A expenses declined 35% yr/yr due to lower legal fees related to licensing activities


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$5.50 mln

$4.20 mln (1 Analyst)


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • Wall Street's median 12-month price target for Birchtech Corp is $15.00, about 1,263.6% above its November 11 closing price of $1.10


Reuters Recommended Reads

  • Nov 12 - Chevron restarts idled Iowa biodiesel plant on Landus soybean deal


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk